Results 161 to 170 of about 87,487 (309)
The contemporary management of prostate cancer
CA: A Cancer Journal for Clinicians, EarlyView.Abstract Prostate cancer is the most common cancer in two thirds of the world, with an expected doubling in both incidence and mortality in the next two decades. No strong environmental associations exist for the development of prostate cancer; therefore, lifestyle measures are unlikely to mitigate this increasing burden.
Deep Chakrabarti +11 more
wiley +1 more source
A CLINICAL CLASSIFICATION OF SEVERITY OF BENIGN PROSTATIC HYPERPLASIA
, 1993 Yukio Homma +3 more
openalex +2 more sources
Diagnosis and Treatment of Benign Prostatic Hyperplasia: Practice Patterns of Primary Care Physicians [PDF]
, 1997 Mary Collins +5 more
openalex +1 more source
Journal of Magnetic Resonance Imaging, Volume 62, Issue 3, Page 673-690, September 2025.ABSTRACT The Prostate Imaging–Reporting and Data System (PI‐RADS) is a widely‐adopted framework for assessing prostate cancer risk using multiparametric MRI. However, as advancements in imaging and data analytics emerge, PI‐RADS faces pressure to integrate novel quantitative techniques, enhanced imaging protocols, and artificial intelligence (AI ...
Omer Tarik Esengur +3 more
wiley +1 more source
Visual Laser Ablation of the Prostate (VLAP) for Benign Prostatic Hyperplasia
, 1994 Τοyoaki Uchida
openalex +2 more sources
Recent Developments in the Optical Control of Adrenergic Signaling
Medicinal Research Reviews, Volume 45, Issue 5, Page 1307-1322, September 2025.ABSTRACT Adrenoceptors (ARs) play a vital role in various physiological processes and are key therapeutic targets. The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution. In this review, we summarize the latest advancements in the
Shuang Shi +4 more
wiley +1 more source
MedComm – Oncology, Volume 4, Issue 3, September 2025.TGF‐β inhibition is emerging as a promising cancer therapy, yet translating laboratory success to bedside implementation has suffered significant setbacks. The associated challenges include adverse drug reactions, inadequate predictive models, and activation of alternative signaling pathways.
Faizah A. Alabi +5 more
wiley +1 more source
Elevated NPM1 and FBL expression correlates with prostate cancer aggressiveness and progression
The Journal of Pathology, Volume 267, Issue 1, Page 56-68, September 2025.Abstract The nucleolus is a membrane‐less body present in the nucleus of the cell. The nucleolus is mainly involved in ribosomal RNA (rRNA) transcription and ribosome biogenesis for protein translation. During cancer formation, nucleolar morphology is altered, and many nucleolar proteins are expressed at a higher level, leading to enhanced ribosome ...
Sarina Saffarian +4 more
wiley +1 more source